Effects of denosumab on peripheral lymphocyte subpopulations
Anno:
2016
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Referee:
No
Nome rivista:
ENDOCRINE
ISSN Rivista:
1355-008X
N° Volume:
53
Numero o Fascicolo:
3
Intervallo pagine:
857-859
Parole chiave:
denosumab, lymphocyte, rheumatoid arthritis
Breve descrizione dei contenuti:
The development of denosumab, a human monoclonal antibody to receptor activator of nuclear factor kappa B ligand (RANKL), represents a novel approach to the prevention of fragility fractures in osteoporosis, skeletal complications of malignancy, and bone erosions in rheumatoid arthritis